Steven Oday
Hematology & Oncology · Santa Monica, CANPI 1518070812
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $192,043 of the $269,846 with a category attached, or 71.2%. E.r. Squibb & Sons, L.L.C. accounts for 86.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $145,209 and has fallen 98.6% since, to $2,100 in 2022. Among hematology & oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 185 payments — averaging $1458.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$232K
- Merck$21K
- Eisai CO., LTD.$14K
- Array Biopharma Inc$3K
- Bristol Myers Squibb$641
- Regeneron Healthcare Solutions, Inc.$24
- plus $51 from 3 others
Across 331 payments — averaging $10,425 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$2.9M
- Incyte Corporation$321K
- Novartis$153K
- E.r. Squibb & Sons, L.L.C.$21K
- Amgen$16K
What the payments were for
- Consulting fees$43,73816%
- Speaking & faculty fees$192,04371%
- Travel & lodging$31,88312%
- Food & beverage$2,1651%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 138 | $232,167 |
| Merck | 25 | $20,596 |
| Eisai CO., LTD. | 3 | $13,750 |
| Array Biopharma Inc | 12 | $2,617 |
| Bristol Myers Squibb | 3 | $641 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| GT Medical Technologies, Inc | 1 | $17 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$269,846 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Santa Monica
- Omid HamidSanta Monica$809K
- Richard FinnSanta Monica$784K
- Zev WainbergSanta Monica$761K
- Saeed SadeghiSanta Monica$696K
- Aditya BardiaSanta Monica$593K
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.